Published by Josh White on 3rd November 2022
(Sharecast News) - Life Science REIT announced on Thursday that, in accordance with the intention it expressed at its initial public offering on AIM, it had decided to apply for its existing shares to be admitted to the premium segment of the main market on the London Stock Exchange.
URL: http://www.digitallook.com/dl/news/story/33083021/...